Is there a role for minimal residual disease monitoring in the management of patients with hairy-cell leukaemia?
Por:
Ortiz-Maldonado V., Villamor N., Baumann T., Aymerich M., Magnano L., Mozas P., Rivas-delgado A., Martínez-Trillos A., Giné E., Campo E., López-Guillermo A., Delgado J.
Publicada:
1 ene 2018
Categoría:
Hematology
Resumen:
[No abstract available]
Filiaciones:
Ortiz-Maldonado V.:
Department of Haematology, Hospital Clínic, IDIBAPS, Barcelona, Spain
Villamor N.:
Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona, Spain
CIBERONC, ISCIII, MINECO, Spain
Baumann T.:
Department of Haematology, Hospital Clínic, IDIBAPS, Barcelona, Spain
CIBERONC, ISCIII, MINECO, Spain
Aymerich M.:
Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona, Spain
CIBERONC, ISCIII, MINECO, Spain
Magnano L.:
Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona, Spain
Mozas P.:
Department of Haematology, Hospital Clínic, IDIBAPS, Barcelona, Spain
Rivas-delgado A.:
Department of Haematology, Hospital Clínic, IDIBAPS, Barcelona, Spain
Martínez-Trillos A.:
Department of Haematology, Hospital Clínic, IDIBAPS, Barcelona, Spain
CIBERONC, ISCIII, MINECO, Spain
Giné E.:
Department of Haematology, Hospital Clínic, IDIBAPS, Barcelona, Spain
CIBERONC, ISCIII, MINECO, Spain
Campo E.:
Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona, Spain
CIBERONC, ISCIII, MINECO, Spain
López-Guillermo A.:
Department of Haematology, Hospital Clínic, IDIBAPS, Barcelona, Spain
CIBERONC, ISCIII, MINECO, Spain
Delgado J.:
Department of Haematology, Hospital Clínic, IDIBAPS, Barcelona, Spain
CIBERONC, ISCIII, MINECO, Spain
|